Novartis has made a dramatic return to the Huntington's disease therapy stage by licensing a candidate from PTC Therapeutics for a whopping $1 billion upfront. The deal – which has a potential total ...
In a potentially pivotal trial, PTC Therapeutics' experimental therapy for Huntington's disease (HD) met its primary endpoint, but questions about the data have raised doubts about the company's ...
Creative Assembly’s Total War 25th anniversary showcase featured a number of major announcements in the strategy series, including a brand new game, a significant update to an existing game, and the ...
The premium tax credit is a refundable credit that helps some taxpayers afford health insurance premiums. The advance PTC lowers the premiums themselves. Many, or all, of the products featured on this ...
NHPC is unwilling to sell its stake in the power trading joint venture although it had, while shelving its buyout plan, said power trading was not its core business. New Delhi: After NHPC Ltd dropped ...
Management believes that the commercial opportunity, combined with its cash reserves, will enable its cash flow to reach breakeven. The drug has been approved in the U.S. and Europe, and PTC ...
PTC Therapeutics (PTCT) has been coming along well as a biotech since it had received FDA approval of SEPHIENCE [sepiapterin] for the treatment of children and adults with phenylketonuria [PKU].
The FDA rejected PTC Therapeutics' NDA for vatiquinone, citing insufficient efficacy evidence and requiring an additional study for resubmission. The MOVE-FA trial, a Phase II/III study, failed to ...
BOSTON, July 30, 2025 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that it is expanding the scope of its collaboration with NVIDIA, the world leader in accelerated computing. PTC is integrating ...
Autodesk Inc. is weighing an acquisition of rival engineering-software provider PTC Inc., according to people familiar with the matter. Autodesk has been working with advisers to evaluate a ...
Investing.com -- PTC Inc. (NASDAQ:PTC) stock soared 9% while Autodesk Inc . (NASDAQ:ADSK) shares fell 2% after Bloomberg reported that Autodesk is considering acquiring the rival engineering-software ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results